Gainers
- Intellia Therapeutics NTLA stock rose 62.0% to $143.91 during Monday's pre-market session. The company's market cap stands at $9.8 billion.
- Reshape Lifesciences RSLS stock increased by 37.16% to $8.23. The company's market cap stands at $28.8 million.
- Anavex Life Sciences AVXL stock increased by 26.78% to $31.38. The company's market cap stands at $2.2 billion.
- Beam Therapeutics BEAM shares rose 21.52% to $114.05. The market value of their outstanding shares is at $7.1 billion.
- Editas Medicine EDIT shares increased by 19.26% to $49.95. The market value of their outstanding shares is at $3.3 billion.
- Catalyst Biosciences CBIO shares rose 13.21% to $5.14. The company's market cap stands at $161.1 million.
Losers
- Exelixis EXEL stock declined by 14.61% to $20.0 during Monday's pre-market session. The company's market cap stands at $6.2 billion.
- Atossa Therapeutics ATOS shares declined by 10.45% to $7.72. The company's market cap stands at $932.7 million.
- Trevena TRVN shares decreased by 10.21% to $1.76. The company's market cap stands at $287.9 million.
- Alnylam Pharmaceuticals ALNY shares fell 9.92% to $158.0. The market value of their outstanding shares is at $18.5 billion.
- Osmotica Pharmaceuticals OSMT shares decreased by 7.94% to $3.48. The company's market cap stands at $218.2 million.
- Adial Pharmaceuticals ADIL stock decreased by 6.46% to $2.32. The company's market cap stands at $42.2 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in